LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 84

Search options

  1. Article ; Online: 18q Deletion Syndrome-Associated Schizophrenia: A Case Report.

    Colijn, Mark A / Crockford, David N

    Neuropsychobiology

    2024  , Page(s) 1–4

    Abstract: Introduction: 18q deletion syndrome is a rare genetic disorder characterized by various neurodevelopmental anomalies and medical issues. Although the occurrence of psychosis has been reported in a small number of cases, details regarding the nature of ... ...

    Abstract Introduction: 18q deletion syndrome is a rare genetic disorder characterized by various neurodevelopmental anomalies and medical issues. Although the occurrence of psychosis has been reported in a small number of cases, details regarding the nature of such symptoms and their response to treatment have not been described.
    Case presentation: We describe a 31-year-old male with a history of speech delays, autistic features, a tethered spinal cord, bilateral vertical talus, subaortic stenosis and aortic regurgitation, recurrent otitis media, mild hearing loss, and hypospadias, who experienced a first episode of psychosis in his late 20s. His psychotic symptoms included auditory hallucinations, various delusions, and disorganization of thought. Although his presentation is atypical in certain ways (e.g., exhibiting highly fluctuant symptoms), he nonetheless meets criteria for schizophrenia. Given his overall clinical picture, chromosomal microarray analysis was completed, which revealed a 19.78 Mb deletion at 18q21.32 from nucleotide 58,226,713 to 78,015,180 (GRCh37). Despite exhibiting a somewhat idiosyncratic response to numerous antipsychotic medications, he eventually achieved partial remission of symptoms with improved insight on relatively low dose oral aripiprazole therapy.
    Conclusion: This is the first in-depth description of 18q deletion syndrome-associated schizophrenia. While our patient's atypical presentation and idiosyncratic response to treatment may be mediated by his comorbid diagnosis of autism, his unusual psychiatric phenotype may alternatively be directly related to his underlying genetic disorder. The description of additional cases in the future will hopefully help clarify matters further.
    Language English
    Publishing date 2024-04-29
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 442239-9
    ISSN 1423-0224 ; 0302-282X
    ISSN (online) 1423-0224
    ISSN 0302-282X
    DOI 10.1159/000538693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The COVID-19 pandemic and its impact on addiction treatment.

    Crockford, David

    The Canadian journal of addiction

    2020  Volume 11, Issue 2, Page(s) 7–8

    Language English
    Publishing date 2020-06-03
    Publishing country Canada
    Document type Editorial
    ZDB-ID 2780140-8
    ISSN 2368-4720
    ISSN 2368-4720
    DOI 10.1097/CXA.0000000000000084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.

    Bahji, Anees / Danilewitz, Marlon / Sloan, Matthew / Tang, Victor / Crockford, David

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

    2024  Volume 196, Issue 10, Page(s) E346–E347

    MeSH term(s) Humans ; Selective Serotonin Reuptake Inhibitors/therapeutic use ; Alcoholism/drug therapy ; Canada ; Alcohol Drinking
    Chemical Substances Selective Serotonin Reuptake Inhibitors
    Language English
    Publishing date 2024-03-17
    Publishing country Canada
    Document type Letter
    ZDB-ID 215506-0
    ISSN 1488-2329 ; 0008-4409 ; 0820-3946
    ISSN (online) 1488-2329
    ISSN 0008-4409 ; 0820-3946
    DOI 10.1503/cmaj.149917-l
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The COVID-19 pandemic and its impact on addiction treatment

    Crockford, David

    Canadian Journal of Addiction

    2020  Volume 11, Issue 2, Page(s) 7–8

    Keywords covid19
    Language English
    Publisher Ovid Technologies (Wolters Kluwer Health)
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2780140-8
    ISSN 2368-4720
    ISSN 2368-4720
    DOI 10.1097/cxa.0000000000000084
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders.

    Bahji, Anees / Danilewitz, Marlon / Crockford, David

    Brain sciences

    2023  Volume 13, Issue 10

    Abstract: Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction, including interventions that focus on prescribing pharmaceutical-grade psychoactive substances, such as opioids, instead of illicit versions, intending to mitigate fatal ...

    Abstract Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction, including interventions that focus on prescribing pharmaceutical-grade psychoactive substances, such as opioids, instead of illicit versions, intending to mitigate fatal overdose risks arising from the variability in potency and additives found in illicit drugs. Stimulants have increasingly been found in the victims of opioid overdoses, further prompting some to argue for the prescription of stimulant medications for individuals with stimulant use disorders. Yet, the evidence supporting this practice remains insufficient. In this communication, we critically examine the existing evidence, challenges, and cautions surrounding the treatment of stimulant use disorder.
    Language English
    Publishing date 2023-10-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci13101416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Assessing research competency development in Canadian psychiatry residency programs: A systematic review and future directions.

    Bahji, Anees / Danilewitz, Marlon / Crockford, David / Delva, Nicholas / Rusak, Benjamin

    SAGE open medicine

    2023  Volume 11, Page(s) 20503121231216846

    Abstract: Objective: We aimed to conduct a systematic review to identify curricular and educational interventions to build research competency among Canadian psychiatry residents and fellows transitioning to the competency-by-design framework.: Methods: The ... ...

    Abstract Objective: We aimed to conduct a systematic review to identify curricular and educational interventions to build research competency among Canadian psychiatry residents and fellows transitioning to the competency-by-design framework.
    Methods: The PRISMA guidelines were followed, searching five databases from their inception to February 2023 for relevant evaluation-type studies exploring research competency among psychiatry residents and fellows. We appraised thestudy's quality using the Joanna Briggs Institute's risk of bias tool for observational designs.
    Results: Overall, 36 original articles met our inclusion criteria. Surveys (
    Conclusions: While many studies have explored best practices in research curricula, the current literature does not inform competency-based models for Canadian psychiatry residency programs incorporating research training requirements. Further description is needed from Canadian psychiatric training bodies regarding appropriate curricula, milestones, and metrics for evaluating research competencies.
    Language English
    Publishing date 2023-12-12
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2735399-0
    ISSN 2050-3121
    ISSN 2050-3121
    DOI 10.1177/20503121231216846
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review.

    Bahji, Anees / Crockford, David / El-Guebaly, Nady

    Journal of studies on alcohol and drugs

    2022  Volume 83, Issue 4, Page(s) 461–469

    Abstract: Objective: This study aims to review the neurobiology and symptomatology of post-acute alcohol withdrawal syndrome (PAWS).: Method: We conducted a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-guided systematic review of ...

    Abstract Objective: This study aims to review the neurobiology and symptomatology of post-acute alcohol withdrawal syndrome (PAWS).
    Method: We conducted a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-guided systematic review of articles from two databases for English-language randomized and nonrandomized studies involving PAWS published between database inception and December 2020.
    Results: Twenty-seven studies met inclusion criteria. PAWS involves predominantly negative affect, which develops in early abstinence and can persist for 4-6 months or longer. Symptoms include anxiety, dysphoria, anhedonia, sleep disturbance, cognitive impairment, cravings, and irritability. PAWS symptoms appear to be risk factors for recurrent alcohol consumption. They have been associated with reported neurobiological differences in evoked potentials; measures of orexins, cortisol, serotonin, and pancreatic polypeptides; and neuroadaptation changes in the nucleus accumbens and the prefrontal cortex.
    Conclusions: There is credible evidence to support the concept of PAWS based on this review's findings. There remains a need to develop and test specific criteria for PAWS. High-quality treatment studies involving agents addressing its neurobiological underpinnings are also recommended.
    MeSH term(s) Humans ; Alcohol Drinking ; Alcoholism ; Craving ; Neurobiology ; Substance Withdrawal Syndrome
    Language English
    Publishing date 2022-05-12
    Publishing country United States
    Document type Journal Article ; Systematic Review
    ZDB-ID 2266450-6
    ISSN 1938-4114 ; 1934-2683 ; 1937-1888 ; 0096-882X
    ISSN (online) 1938-4114 ; 1934-2683
    ISSN 1937-1888 ; 0096-882X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review.

    Bahji, Anees / Crockford, David / El-Guebaly, Nady

    Journal of studies on alcohol and drugs

    2022  Volume 83, Issue 4, Page(s) 470–479

    Abstract: Objective: This article reviews research on post-acute alcohol withdrawal syndrome (PAWS) management.: Method: We conducted a PRISMA (Preferred Reporting Items for Systematic Revision and Meta-Analyses)-guided scoping review of the published PAWS ... ...

    Abstract Objective: This article reviews research on post-acute alcohol withdrawal syndrome (PAWS) management.
    Method: We conducted a PRISMA (Preferred Reporting Items for Systematic Revision and Meta-Analyses)-guided scoping review of the published PAWS literature, searching six electronic databases (from their inception through December 2020) for English-language randomized and nonrandomized studies.
    Results: A total of 16 treatment studies met the inclusion criteria. The strength of evidence overall for pharmacologic treatments is low, with often only short-term results being reported, small treatment samples used, or inconsistent results found. However, for negative affect and sleep symptoms, more evidence supports using gabapentinoids (gabapentin and pregabalin) and anticonvulsants (carbamazepine and oxcarbazepine). Although preliminary data support acamprosate, there were no controlled trials. Despite an older treatment trial showing some positive data for amitriptyline for mood, the clinical measures used were problematic, and side effects and safety profile limit its utility. Finally, there is no evidence that melatonin and other agents (homatropine, Proproten-100) show PAWS symptoms.
    Conclusions: Although there is some evidence for targeted pharmacotherapy for treating specific PAWS symptoms, there are few recent, robust, placebo-controlled trials, and the level of evidence for treatment efficacy is low.
    MeSH term(s) Alcoholism/drug therapy ; Anticonvulsants/therapeutic use ; Benzodiazepines ; Gabapentin ; Humans ; Substance Withdrawal Syndrome/drug therapy
    Chemical Substances Anticonvulsants ; Benzodiazepines (12794-10-4) ; Gabapentin (6CW7F3G59X)
    Language English
    Publishing date 2022-08-08
    Publishing country United States
    Document type Journal Article ; Systematic Review
    ZDB-ID 2266450-6
    ISSN 1938-4114 ; 1934-2683 ; 1937-1888 ; 0096-882X
    ISSN (online) 1938-4114 ; 1934-2683
    ISSN 1937-1888 ; 0096-882X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.

    Bahji, Anees / Crockford, David / Brasch, Jennifer / Schutz, Christian / Buckley, Leslie / Danilewitz, Marlon / Dubreucq, Simon / Mak, Michael / George, Tony P

    Canadian journal of psychiatry. Revue canadienne de psychiatrie

    2024  , Page(s) 7067437241231128

    Language English
    Publishing date 2024-04-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 304227-3
    ISSN 1497-0015 ; 0008-4824 ; 0706-7437
    ISSN (online) 1497-0015
    ISSN 0008-4824 ; 0706-7437
    DOI 10.1177/07067437241231128
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top